| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.00043 | 1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.00038 | 1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.00033 | 1 |